Ajay Madan - Chief Development Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ajay Madan since 11/21/2023

Holdings reported by Ajay Madan for Crinetics Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 177K $6.66M $37.65 Mar 1, 2022 Direct
Common Stock (right to buy) 65.4K $1.12M $17.12 Feb 28, 2022 Direct Common Stock

Transactions reported by Ajay Madan for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.